SCHEMBL3177044

SCHEMBL3177044

COc1ccc(C(=O)NCCNc2nc(-c3ccc(Cl)cc3)nc(NCCNC(C)=O)c2C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
MAPT P10636 4/20 0.52
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C19 P33261 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
CFTR P13569 1/20 0.46
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 5/20 0.45
RAB9A P51151 3/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LTA4H P09960 1/20 0.44
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3161933 0.90 CYP1A2 (0.58) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3163026 0.89 MEN1 (0.50) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3175921 0.88 TRPV1 (0.51) KMT2AMEN1MAPTCYP3A4ALDH1A1
SCHEMBL3156001 0.87 ADORA2A (0.56) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3171746 0.87 TP53 (0.49) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3167813 0.87 ADORA2A (0.56) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3156347 0.87 TP53 (0.52) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3170716 0.87 MAPT (0.53) KMT2AMEN1MAPTCLK4NPC1
SCHEMBL3170473 0.87 NPC1 (0.54) KMT2AMEN1MAPTCYP1A2CYP3A4
SCHEMBL3175707 0.86 ALDH1A1 (0.53) KMT2AMEN1MAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed